Supplementary Methods, Figure Legend, Tables 1 - 5 from Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G₂–M Transition Genes

PDF file - 229K, Supplementary Table S1. Correlation of clinical features of the HCC patients and MEF2D expression analyzed by immunohistochemistry Supplementary Table S2. Correlation of pathological features of the HCC patients and MEF2Dexpression analyzed by immunohistochemistry Supplementary Table S3. Information of predicted MEF2 binding sites in the promoters of RPRM, CDKN1A, GADD45Aand GADD45B Supplementary Table S4. Lentiviruses and adenoviruses used in this study Supplementary Table S5. Sequences of primers used for qRT-PCR